Healthcare provider profile · identity verified

Mohammed Memon

Physician Assistant · HINSDALE, IL · NPI 1922519149

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lidocaine	Lidocaine	414	106
Atorvastatin Calcium	Atorvastatin Calcium	343	99
Amlodipine Besylate	Amlodipine Besylate	323	77
Gabapentin	Gabapentin	300	68
Albuterol Sulfate Hfa	Albuterol Sulfate	288	65
Furosemide	Furosemide	201	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	200	34
Diclofenac Sodium	Diclofenac Sodium	188	63
Lisinopril	Lisinopril	184	44
Pantoprazole Sodium	Pantoprazole Sodium	151	43
Prednisone	Prednisone	146	65
Hydrochlorothiazide	Hydrochlorothiazide	124	27
Metoprolol Succinate	Metoprolol Succinate	124	44
Metformin Hcl	Metformin Hcl	123	40
Alprazolam	Alprazolam	116	22
Baclofen	Baclofen	115	22
Losartan Potassium	Losartan Potassium	111	34
Lactulose	Lactulose	109	55
Triamcinolone Acetonide	Triamcinolone Acetonide	108	36
Tamsulosin Hcl	Tamsulosin Hcl	104	23
Eliquis	Apixaban	100	22
Tramadol Hcl	Tramadol Hcl	100	29
Carvedilol	Carvedilol	99	25
Omeprazole	Omeprazole	92	22
Potassium Chloride	Potassium Chloride	92	28
Levothyroxine Sodium	Levothyroxine Sodium	88	19
Famotidine	Famotidine	87	19
Metoprolol Tartrate	Metoprolol Tartrate	78	21
Hydralazine Hcl	Hydralazine Hcl	72	19
Acarbose	Acarbose	71	suppressed
Levofloxacin	Levofloxacin	71	55
Azithromycin	Azithromycin	69	54
Linzess	Linaclotide	69	15
Donepezil Hcl	Donepezil Hcl	68	13
Nifedipine Er	Nifedipine	67	22
Montelukast Sodium	Montelukast Sodium	63	11
Fluticasone Propionate	Fluticasone Propionate	61	14
Ozempic	Semaglutide	60	11
Ammonium Lactate	Ammonium Lactate	59	16
Simvastatin	Simvastatin	57	13
Enalapril Maleate	Enalapril Maleate	55	11
Trazodone Hcl	Trazodone Hcl	55	12
Ventolin Hfa	Albuterol Sulfate	55	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	53	37
Nystatin	Nystatin	52	13
Ibuprofen	Ibuprofen	48	11
Acetaminophen-Codeine	Acetaminophen With Codeine	47	16
Clopidogrel	Clopidogrel Bisulfate	46	14
Meclizine Hcl	Meclizine Hcl	41	18
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Allopurinol	Allopurinol	37	13
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	36	14
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	34	suppressed
Spironolactone	Spironolactone	33	11
Memantine Hcl	Memantine Hcl	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Ssd	Silver Sulfadiazine	32	15
Clonidine Hcl	Clonidine Hcl	31	suppressed
Megestrol Acetate	Megestrol Acetate	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	19
Silver Sulfadiazine	Silver Sulfadiazine	30	19
Vitamin D2	Ergocalciferol (Vitamin D2)	30	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Levetiracetam	Levetiracetam	29	11
Ketoconazole	Ketoconazole	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Atenolol	Atenolol	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Atrovent Hfa	Ipratropium Bromide	25	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	11
Latanoprost	Latanoprost	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Valsartan	Valsartan	19	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Torsemide	Torsemide	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Glipizide	Glipizide	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Dulera	Mometasone/Formoterol	15	suppressed
Enulose	Lactulose	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Primidone	Primidone	15	suppressed
Tramadol Hcl Er	Tramadol Hcl	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Jentadueto Xr	Linagliptin/Metformin Hcl	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nyamyc	Nystatin	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cephalexin	Cephalexin	12	11
Colchicine	Colchicine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Ibu	Ibuprofen	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error